文献速递小儿神经外科与脑积水功能神经外科

成人慢性梗阻性脑积水初级内镜下第三脑室造瘘术后的认知与步态结局

Cognitive and gait outcomes after primary endoscopic third ventriculostomy in adults with chronic obstructive hydrocephalus.
PubMed 文献 · J Neurosurg · 2021-09-17

本研究基于成人脑积水临床研究网络前瞻性注册数据,纳入42例未治疗的先天性或获得性梗阻性脑积水成人患者,评估初级内镜下第三脑室造瘘术(ETV)对步态速度和整体认知的短期与长期疗效。结果显示步态速度在短期和长期均显著改善,认知在短期有统计学改善但未达临床意义,长期则达统计学和临床显著改善。

要点

  • 初级ETV可安全改善成人慢性梗阻性脑积水患者的步态和认知症状。
  • 步态速度短期和长期均显著提高,中位个体内变化分别为0.3 m/sec和0.4 m/sec。
  • 认知短期改善未达临床意义,长期MoCA中位个体内变化+2分,具临床意义。

核心结论

  • 初级ETV可安全改善成人慢性梗阻性脑积水患者的步态和认知功能障碍,步态速度和整体认知显著改善,ETV后恶化罕见。

研究设计与样本

  • 前瞻性队列研究,通过成人脑积水临床研究网络患者注册库前瞻性纳入患者。
  • 纳入既往未治疗的先天性或获得性梗阻性脑积水成人患者,仅分析有ETV前后步态分析和/或MoCA记录者。
  • 共74例接受初级ETV,42例纳入分析,32例因无法完成前后评估被排除;42例平均年龄51.9±17.1岁(范围19-79岁),女性19例(45.2%)。

主要发现

  • 步态短期随访队列(平均4.7±4.1个月,35例)基线中位步态速度0.9 m/sec(IQR 0.7-1.3 m/sec),ETV后中位1.3 m/sec(IQR 1.1-1.4 m/sec),中位个体内变化0.3 m/sec(IQR 0.0-0.6 m/sec,p < 0.001)。
  • 步态长期随访队列(平均14±2.8个月,12例)基线中位速度0.7 m/sec(IQR 0.6-1.3 m/sec),ETV后中位1.3 m/sec(IQR 1.1-1.7 m/sec),中位个体内变化0.4 m/sec(IQR 0.2-0.6 m/sec,p < 0.001)。
  • 认知短期随访队列(平均4.6±4.0个月,38例)基线中位MoCA总分24/30(IQR 23-27),ETV后26/30(IQR 24-28),中位个体内变化+1分(IQR 0-2分,p < 0.001),但无临床意义。
  • 认知长期随访队列(平均14±3.1个月,15例)基线中位MoCA总分23/30(IQR 22-27),ETV后26/30(IQR 25-28),中位个体内变化+2分(IQR 1-3分,p = 0.007),具统计学和临床显著意义。
  • 手术并发症轻微;先天性病因31例(73.8%),其中导水管狭窄23例(54.8%),获得性病因11例(26.2%)。

临床怎么用

  • 对于成人慢性梗阻性脑积水,初级ETV可考虑作为改善步态和认知功能的治疗选择。
  • 术后应关注步态速度和整体认知的评估,短期认知改善可能未达临床意义,长期随访可见显著获益。

局限性

  • 仅42例纳入分析,32例因无法完成前后评估被排除,可能存在选择偏倚。
  • 长期随访样本量较小(步态12例,认知15例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The object of this study was to determine the short- and long-term efficacy of primary endoscopic third ventriculostomy (ETV) on cognition and gait in adults with chronic obstructive hydrocephalus. METHODS: Patients were prospectively accrued through the Adult Hydrocephalus Clinical Research Network patient registry. Patients with previously untreated congenital or acquired obstructive hydrocephalus were included in this study. Gait velocity was assessed using a 10-m walk test. Global cognition was assessed with the Montreal Cognitive Assessment (MoCA). Only patients with documented pre- and post-ETV gait analysis and/or pre- and post-ETV MoCA were included. RESULTS: A total of 74 patients had undergone primary ETV, 42 of whom were analyzed. The remaining 32 patients were excluded, as they could not complete both pre- and post-ETV assessments. The mean age of the 42 patients, 19 (45.2%) of whom were female, was 51.9 ± 17.1 years (range 19-79 years). Most patients were White (37 [88.1%]), and the remainder were Asian. Surgical complications were minor. Congenital etiologies occurred in 31 patients (73.8%), with aqueductal stenosis in 23 of those patients (54.8%). The remaining 11 patients (26.2%) had acquired cases. The gait short-term follow-up cohort (mean 4.7 ± 4.1 months, 35 patients) had a baseline median gait velocity of 0.9 m/sec (IQR 0.7-1.3 m/sec) and a post-ETV median velocity of 1.3 m/sec (IQR 1.1-1.4 m/sec). Gait velocity significantly improved post-ETV with a median within-patient change of 0.3 m/sec (IQR 0.0-0.6 m/sec, p < 0.001). Gait velocity improvements were sustained in the long term (mean 14 ± 2.8 months, 12 patients) with a baseline median velocity of 0.7 m/sec (IQR 0.6-1.3 m/sec), post-ETV median of 1.3 m/sec (IQR 1.1-1.7 m/sec), and median within-patient change of 0.4 m/sec (IQR 0.2-0.6 m/sec, p < 0.001). The cognitive short-term follow-up cohort (mean 4.6 ± 4.0 months, 38 patients) had a baseline median MoCA total score (MoCA TS) of 24/30 (IQR 23-27) that improved to 26/30 (IQR 24-28) post-ETV. The median within-patient change was +1 point (IQR 0-2 points, p < 0.001). However, this change is not clinically significant. The cognitive long-term follow-up cohort (mean 14 ± 3.1 months, 15 patients) had a baseline median MoCA TS of 23/30 (IQR 22-27), which improved to 26/30 (IQR 25-28) post-ETV. The median within-patient change was +2 points (IQR 1-3 points, p = 0.007), which is both statistically and clinically significant. CONCLUSIONS: Primary ETV can safely improve symptoms of gait and cognitive dysfunction in adults with chronic obstructive hydrocephalus. Gait velocity and global cognition were significantly improved, and the worsening of either was rare following ETV.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Zwimpfer TJ, Salterio N, Williams MA, et al. Cognitive and gait outcomes after primary endoscopic third ventriculostomy in adults with chronic obstructive hydrocephalus. J Neurosurg. 2021. PMID: 34534954. doi:10.3171/2021.3.JNS203424

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。